Additionally, semaglutide GLP-1 has been shown to slow down gastric emptying, leading to increased feelings of fullness and potentially altering nutrient absorption and digestion
As long as incretin mimetics commonly referred to as GLP-1s, and how well refer to them in this article like Zepbound, Wegovy, and Ozempic continue to appear on the official FDA drug shortage list, compounding pharmacies can continue to make these medications
The FDA recently reported its concerns on fraudulent compounded GLP-1s in the market, where some dont even contain semaglutide at all
Relationship between intestinal microbiota and ulcerative colitis: mechanisms and clinical application of probiotics and fecal microbiota transplantation
Nausea, vomiting, and diarrhea are consistently the top most common side effects